Encompass Health Corp
Health Care
Encompass Health Corp (EHC) Stock News
The latest EHC headlines and market coverage — 8 recent stories, updated throughout the day.
- Zacks Investment Research·Neutral
Encompass Health (EHC) Reports Q3 Earnings: What Key Metrics Have to Say
Encompass Health reported Q3 2026 revenue of $1.61 billion, up 8.9% year-over-year, beating consensus estimates by 0.63%. EPS came in at $1.52, exceeding the consensus estimate of $1.38 by 10.15%. Key metrics showed net patient revenue per discharge of $22,543 (above estimates) and inpatient revenues up 9.9% year-over-year, though discharges slightly missed expectations and other operating revenues declined 19.5%. The stock holds a Zacks Rank #3 (Hold) rating and has underperformed the broader market over the past month.
- GlobeNewswire Inc.·
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz is investigating GE HealthCare Technologies for potential federal securities law violations. The investigation follows the company's April 2026 earnings report, which revealed a PDx supplier recall that impacted profit performance and margins, leading to reduced full-year EPS guidance and a 13.2% stock price decline. The company's CFO also stepped down in July 2026.
- Zacks Investment Research·
GE HealthCare (GEHC) Upgraded to Buy: Here's Why
GE HealthCare Technologies (GEHC) received an upgrade to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The company is expected to earn $4.93 per share for fiscal year 2026, with analysts steadily raising estimates over the past three months. The upgrade positions GEHC in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals.
- Zacks Investment Research·
GEHC or SYK: Which Is the Better Value Stock Right Now?
In a comparison of two Medical-Products sector stocks, GE HealthCare Technologies (GEHC) emerges as the superior value option for value investors. GEHC has a Zacks Rank of #2 (Buy) with improving earnings outlook, a lower forward P/E of 12.98 versus Stryker's 18.76, and a Value grade of A compared to Stryker's C grade. Key valuation metrics favor GEHC, including a lower PEG ratio (1.69 vs 1.76) and P/B ratio (2.63 vs 4.5).
- Zacks Investment Research·
GEHC vs. HAE: Which Stock Is the Better Value Option?
In a comparison of two medical products stocks, GE HealthCare Technologies (GEHC) emerges as the more attractive value investment option compared to Haemonetics (HAE). GEHC holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a lower forward P/E ratio of 14.54 and P/B ratio of 2.95. HAE, ranked #3 (Hold) with a Value grade of C, has a higher forward P/E of 19.67 and P/B of 5.64, suggesting GEHC offers better value metrics and a more improving earnings outlook.
- GlobeNewswire Inc.·
Important Notice to Long-Term Shareholders of EquipmentShare.com, Inc. (NASDAQ: EQPT); Insulet Corporation (NASDAQ: PODD); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (f/k/a New Era Helium (NASDAQ: NEHC)); and Planet Fitness, Inc. (NYSE: PLNT): Grabar Law Office is Investigating Claims on Your Behalf
Grabar Law Office has initiated multiple shareholder investigations into alleged securities fraud and fiduciary duty breaches at EquipmentShare.com, Insulet Corporation, New Era Energy & Digital, and Planet Fitness. The investigations allege undisclosed related-party transactions, defective manufacturing controls, misleading statements about business progress, and false marketing claims that caused shareholders to purchase securities at artificially inflated prices.
- GlobeNewswire Inc.·
Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (formerly known as New Era Helium (NASDAQ: NEHC)); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your Behalf
Grabar Law Office announced investigations into multiple publicly traded companies on behalf of shareholders, alleging breaches of fiduciary duties and securities law violations. The investigations cover Erasca (misleading statements about ERAS-0015 drug candidate and patent infringement), Insulet (defective manufacturing controls leading to product recalls), New Era Energy & Digital (overstated project progress and fraudulent oil-and-gas schemes), Power Solutions International (overstated sales demand and understated manufacturing costs), Hub Group, Planet Fitness, Primoris Services, EquipmentShare.com, GPGI, Photronics, and Via Transportation. Shareholders who meet specific holding criteria may seek damages and corporate governance reforms at no cost.
- GlobeNewswire Inc.·
GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.
GE HealthCare reported Q1 2026 earnings that missed consensus estimates and cut full-year guidance due to a PDx supplier issue. The stock declined 13% following the announcement. Law firm Kirby McInerney LLP is investigating potential securities law violations by the company and its senior management.